Onyx is now licensed to manufacture commercial API from our UK facility

Ensuring a Robust Strategy to Navigate the Development of Challenging APIs

Technological advancements such as in silico screening tools and artificial intelligence have increased the number of small molecules in the development pipeline. However, these molecules often exhibit significant challenges, such as suboptimal physiochemical characteristics, and powder handling properties. For these molecules, a robust development strategy is essential.

In this article, Dr Julian Northen highlights the importance of taking a pragmatic approach and provides strategic insight for navigating the complexities associated with the development of complicated small molecules.

Click here to learn more.